Clinical Trials Directory

Trials / Completed

CompletedNCT03920800

Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Catherine Vanpachterbeke · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers

Summary

Lesions classified as "High Grade Squamous Intra-epithelial Lesions" (HSIL) are pre-cervical lesions of the cervix, induced by infection with the Human Papilloma Virus (HPV). The detection and proper management of these lesions greatly reduces the incidence of invasive cervical cancer. Pap smear remains the most effective tool for early detection of low and high-grade cervical lesions. In Belgium, screening for cervical cancer is recommended every 3 years for women between 25 and 65 years old. HPV is a virus who possesses certain oncogenic genes who have the ability to inactivate tumor suppressor genes in the host cell. This promotes a tumorigenesis process within the tissues affected by the virus. The majority of human papillomavirus infections are transient and spontaneously cleared by host defense mechanisms, especially in the first two years after exposure. However, 10-20% of infections persist latently and may eventually lead to progression to invasive cervical cancer. Even high-grade lesions kan naturally be cleared, even more so if the patient is young and immuno-competent. Therefore, the management of HSIL lesions in young women has been modified and consists of adopting mainly a conservative attitude, with controls every 6 months for 2 years. This management makes it possible to avoid unnecessary conizations of the cervix which, in young nulliparous patients, are not devoid of heavy obstetric consequences during subsequent pregnancies (premature birth, perinatal mortality). Cervical conization will only be considered for lesions that progress during follow-up or that persist beyond 2 years. However, this type of follow-up requires that patients be compliant. Our study has two main objectives: * to determine the compliance of CHU Brugmann Hospital patients who have been proposed a conservative strategy for the management of HSIL lesions. * to identify the predictive factors for the persistence and / or progression of high-grade pre-cancerous dysplastic lesions.

Conditions

Interventions

TypeNameDescription
OTHERData extraction from medical filesData extraction from medical files
BIOLOGICALImmunohistochemistryImmunohistochemistry with Ki67 and p16 antibodies on residual samples, if this had not been foreseen in the standard of care management of the patient.

Timeline

Start date
2019-03-01
Primary completion
2019-11-20
Completion
2019-11-20
First posted
2019-04-19
Last updated
2022-07-20

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03920800. Inclusion in this directory is not an endorsement.